HOME >> MEDICINE >> NEWS
HUP welcomes a Swedish invasion

The Hospital of the University of Pennsylvania (HUP) is ready for a very traumatic visit. In conjunction with Sweden's Linkoping University's Center for Disaster Medicine and Traumatology, HUP will be hosting four sets of four general surgeons, who will each get a two-week course in Trauma and Surgical Critical Care at one of the country's busiest hospitals.

"In Sweden they see some blunt force trauma, but very few penetrating injuries," said Benjamin Braslow, MD, Director of the International Program for the Division of Trauma and Critical Care.

The Swedish surgical teams are here as visitors, not physicians. They will observe in the Operating Room and Trauma Bay and learn different techniques. "The training they receive will be invaluable. These General Surgeons may eventually go off to war and have no actual training on penetrating injuries," explained Donald Kauder, MD, Vice Chief of the Division of Trauma and Critical Care. "They come here to learn because of our reputation as a Trauma Center. HUP has a good blend of patient volume and the outstanding teaching facilities that an intense training course like this requires."

Upon completion of their stay, each member of the Swedish Team will have accumulated a series of cases worthy of further study. "Between the observation and the case reports they will have a much better understanding just in case they are ever presented with something similar," added Braslow. "It's a natural part of what we do so we are more than happy to help."

The program's roots date from 1998. That year, the Swedish government saw the need to further educate the country's surgeons in the area of trauma care. HUP began sending its doctors there for one week in November to give lectures, go over lab work, and to present an overview of various trauma scenarios. Over time, the Swedish surgeons arranged to visit HUP in order to get first-hand experience in dealing with major trauma cases.

Similar prog
'"/>

Contact: Rick Cushman
rick.cushman@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
17-Feb-2006


Page: 1 2

Related medicine news :

1. Frazer welcomes Federal Government decision on Gardasil
2. Pharmaceutical industry welcomes Labor Partys Innovation Blueprint
3. AAMRI welcomes Canberras fresh commitment to medical research funding
4. Industry welcomes massive Victorian investment in medical research
5. Oxford Immunotec welcomes UK NICE guideline on tuberculosis as disease incidence continues to rise
6. NMDP welcomes IOM recommendation for fully integrated cord blood system
7. Use of Swedish snus is linked to a doubled risk of pancreatic cancer
8. Swedish snus much safer than smoking but linked to pancreatic cancer
9. Swedish massage benefits osteoarthritis patients
10. ESAs first Swedish astronaut to fly to the ISS
11. Unique results from Swedish study of HIV vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HUP welcomes Swedish invasion

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: